Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 124630502 | 12463050 | 2 | F | 20160523 | 20160628 | 20160614 | 20160831 | PER | US-JNJFOC-20160522327 | JANSSEN | 60.89 | YR | A | M | Y | 106.60000 | KG | 20160831 | CN | US | US |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 124630502 | 12463050 | 1 | PS | STELARA | USTEKINUMAB | 1 | Subcutaneous | N | FK502MD | 125261 | 90 | MG | SOLUTION FOR INJECTION | ||||||
| 124630502 | 12463050 | 2 | C | LIPITOR | ATORVASTATIN CALCIUM | 1 | Oral | 0 | 40 | MG | UNSPECIFIED | BID | |||||||
| 124630502 | 12463050 | 3 | C | METHOTREXATE. | METHOTREXATE | 1 | Oral | 0 | 2.5 | MG | TABLETS | ||||||||
| 124630502 | 12463050 | 4 | C | METOPROLOL. | METOPROLOL | 1 | Oral | 0 | 25 | MG | UNSPECIFIED | BID | |||||||
| 124630502 | 12463050 | 5 | C | METOPROLOL. | METOPROLOL | 1 | Oral | 0 | 50 | MG | UNSPECIFIED | BID | |||||||
| 124630502 | 12463050 | 6 | C | PROTONIX | PANTOPRAZOLE SODIUM | 1 | Unknown | 0 | 40 | MG | UNSPECIFIED | QOD | |||||||
| 124630502 | 12463050 | 7 | C | ASPIRIN. | ASPIRIN | 1 | Oral | 0 | 81 | MG | UNSPECIFIED | BID | |||||||
| 124630502 | 12463050 | 8 | C | FOLIC ACID. | FOLIC ACID | 1 | Oral | 0 | 1 | MG | UNSPECIFIED | ||||||||
| 124630502 | 12463050 | 9 | C | ALPRAZOLAM. | ALPRAZOLAM | 1 | Oral | 0 | 2 | MG | UNSPECIFIED | ||||||||
| 124630502 | 12463050 | 10 | C | LIPITOR | ATORVASTATIN CALCIUM | 1 | Oral | 0 | 40 | MG | UNSPECIFIED |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 124630502 | 12463050 | 1 | Psoriatic arthropathy |
| 124630502 | 12463050 | 2 | Blood cholesterol |
| 124630502 | 12463050 | 3 | Psoriatic arthropathy |
| 124630502 | 12463050 | 4 | Blood pressure measurement |
| 124630502 | 12463050 | 5 | Blood pressure measurement |
| 124630502 | 12463050 | 6 | Gastric disorder |
| 124630502 | 12463050 | 7 | Cardiac disorder |
| 124630502 | 12463050 | 9 | Anxiety |
| 124630502 | 12463050 | 10 | Blood cholesterol |
Outcome of event
| no results found |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 124630502 | 12463050 | Drug dose omission | |
| 124630502 | 12463050 | Syringe issue |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| Event ID | CASEID | DSG DRUG SEQ | START DT | END DT | DUR | DUR COD |
|---|---|---|---|---|---|---|
| 124630502 | 12463050 | 1 | 201601 | 0 | ||
| 124630502 | 12463050 | 3 | 201601 | 0 | ||
| 124630502 | 12463050 | 4 | 201604 | 0 | ||
| 124630502 | 12463050 | 5 | 201604 | 0 | ||
| 124630502 | 12463050 | 8 | 201601 | 0 |